Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Investigating the role of the microbiota in pulmonary fibrosis using defined bacterial communities in mice
EF 2022-23
Résumé
Idiopathic pulmonary fibrosis is a chronic lung disease that can lead to other serious lung complications like cancer, blood clots, and death. Fibrosis can occur in any organ of the body and is caused by the development of cells called myofibroblasts, proposed to arise from precursors called universal fibroblasts. Fibroblasts are responsible for tissue structure by secreting connective tissue proteins. Myofibroblasts on the other hand secrete an excess of these proteins, resulting in tissue rigidity and scarring. To investigate the factors that contribute to the transition of universal fibroblasts into myofibroblast cells, we aim to investigate the effects of bacterial communities in the lungs and gut on lung fibrosis severity. Many human organs are home to bacterial communities called a microbiota, and at mucosal sites like the lung and gut, bacteria and the metabolites that they produce can interact with cells of the immune system, which allows crosstalk between the gut, lung, and immune system. We propose that a microbiota which is imbalanced, termed “dysbiotic”, might combine with other factors, such as lung damage, macrophage infiltration, and chemotherapeutic exposure, to affect myofibroblast activation. This project will involve comparing the immune cells present in mice with two different, defined gut microbiotas and determining how the immune cells, gut bacteria, and lung bacteria change and contribute to a fibrotic state. The results of this research could reveal how the microbiota influences immune cell populations during disease states and reveal avenues for preventative or therapeutic approaches to fibrosis that target implicated microbes and their metabolites.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
486049
Name
Visser Grace V
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of the microbiota in pulmonary fibrosis using defined bacterial communities in mice
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bacteria; Fibroblast; Fibrosis; Gut Microbiota; Lung Microbiota; Metabolites; Microbiome; Microbiota; Myofibroblast; Pulmonary Fibrosis
Abstract
Idiopathic pulmonary fibrosis is a chronic lung disease that can lead to other serious lung complications like cancer, blood clots, and death. Fibrosis can occur in any organ of the body and is caused by the development of cells called myofibroblasts, proposed to arise from precursors called universal fibroblasts. Fibroblasts are responsible for tissue structure by secreting connective tissue proteins. Myofibroblasts on the other hand secrete an excess of these proteins, resulting in tissue rigidity and scarring. To investigate the factors that contribute to the transition of universal fibroblasts into myofibroblast cells, we aim to investigate the effects of bacterial communities in the lungs and gut on lung fibrosis severity. Many human organs are home to bacterial communities called a microbiota, and at mucosal sites like the lung and gut, bacteria and the metabolites that they produce can interact with cells of the immune system, which allows crosstalk between the gut, lung, and immune system. We propose that a microbiota which is imbalanced, termed “dysbiotic”, might combine with other factors, such as lung damage, macrophage infiltration, and chemotherapeutic exposure, to affect myofibroblast activation. This project will involve comparing the immune cells present in mice with two different, defined gut microbiotas and determining how the immune cells, gut bacteria, and lung bacteria change and contribute to a fibrotic state. The results of this research could reveal how the microbiota influences immune cell populations during disease states and reveal avenues for preventative or therapeutic approaches to fibrosis that target implicated microbes and their metabolites.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Visser, Grace V
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~